Narcotics and Sedative Use in Preterm Neonates

Objectives To evaluate patterns of narcotic and sedative use in neonatal intensive care units (NICUs) across Canada using data collected by the Canadian Neonatal Network. Study design We conducted a retrospective observational cohort study of preterm neonates at 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2017-01, Vol.180, p.92-98.e1
Hauptverfasser: Borenstein-Levin, Liron, MD, Synnes, Anne, MDCM, MHSc, Grunau, Ruth E., PhD, Miller, Steven P., MDCM, MAS, Yoon, Eugene W., MSc, Shah, Prakesh S., MD, MSc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 98.e1
container_issue
container_start_page 92
container_title The Journal of pediatrics
container_volume 180
creator Borenstein-Levin, Liron, MD
Synnes, Anne, MDCM, MHSc
Grunau, Ruth E., PhD
Miller, Steven P., MDCM, MAS
Yoon, Eugene W., MSc
Shah, Prakesh S., MD, MSc
description Objectives To evaluate patterns of narcotic and sedative use in neonatal intensive care units (NICUs) across Canada using data collected by the Canadian Neonatal Network. Study design We conducted a retrospective observational cohort study of preterm neonates at 
doi_str_mv 10.1016/j.jpeds.2016.08.031
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852784309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022347616306989</els_id><sourcerecordid>1852784309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-7bb001494239cec766a6393a48fe7fd4068ed4f5a076de54a70f81433bd98d4f3</originalsourceid><addsrcrecordid>eNqFkU1LxDAQhoMoun78AkF69NI6abL5OCiI-AWignoO2WQKqd12TbqC_96sqx68eBqGed95mWcIOaRQUaDipK3aBfpU1bmpQFXA6AaZUNCyFIqxTTIBqOuScSl2yG5KLQBoDrBNdmopKNeMTkh1b6MbxuBSYXtfPKG3Y3jH4iVhEfriMeKIcV7c49DbEdM-2Wpsl_Dgu-6Rl6vL54ub8u7h-vbi_K50nPKxlLMZQE7gNdMOnRTCCqaZ5apB2XgOQqHnzdSCFB6n3EpoFOWMzbxWecD2yPF67yIOb0tMo5mH5LDrbI_DMhmqprVUnIHOUraWujikFLExixjmNn4YCmYFyrTmC5RZgTKgTAaVXUffAcvZHP2v54dMFpyuBZjPfA8YTXIBe4c-RHSj8UP4J-Dsj991oQ_Odq_4gakdlrHPBA01qTZgnla_Wr2KCgZCK80-ARuNjVw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852784309</pqid></control><display><type>article</type><title>Narcotics and Sedative Use in Preterm Neonates</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Borenstein-Levin, Liron, MD ; Synnes, Anne, MDCM, MHSc ; Grunau, Ruth E., PhD ; Miller, Steven P., MDCM, MAS ; Yoon, Eugene W., MSc ; Shah, Prakesh S., MD, MSc</creator><creatorcontrib>Borenstein-Levin, Liron, MD ; Synnes, Anne, MDCM, MHSc ; Grunau, Ruth E., PhD ; Miller, Steven P., MDCM, MAS ; Yoon, Eugene W., MSc ; Shah, Prakesh S., MD, MSc ; Canadian Neonatal Network Investigators</creatorcontrib><description>Objectives To evaluate patterns of narcotic and sedative use in neonatal intensive care units (NICUs) across Canada using data collected by the Canadian Neonatal Network. Study design We conducted a retrospective observational cohort study of preterm neonates at &lt;33 weeks' gestation and admitted to a participating Canadian Neonatal Network NICU. The proportion of all neonates who received sedative(s), narcotic(s), or either sedative(s), narcotic(s), or both during their NICU stay was calculated for each year. Because opioids are used for premedication before intubation, only continuous infusions of a narcotic drug were included. Variation in narcotics and sedative usage between sites in 2014 was determined using logistic regression analysis, with adjustment for gestational age, surgery, and mechanical ventilation. Results Of 20 744 neonates, 29% of neonates received a narcotic, a sedative, or both; 23% received a narcotic and 17% a sedative. Although no clinically significant changes in drug exposure were documented during the 5-year period, there were statistically significant differences in narcotic and sedative use between sites, ranging from 3% to 41% for narcotic and 2% to 48% for sedative use (aORs 0.2-5.7 and 0.1-15, respectively, P  &lt; .05). Conclusions Exposure to narcotic or sedative agents is highly variable in preterm neonates across Canada despite concerns of adverse outcomes associated with these drugs. The tremendous variation in practice suggests that further research on their current usage, as well as identifying optimal practice procedures is warranted.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2016.08.031</identifier><identifier>PMID: 27614931</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Canada ; Cohort Studies ; Drug Utilization - statistics &amp; numerical data ; Humans ; Hypnotics and Sedatives - therapeutic use ; Infant, Newborn ; Infant, Premature ; Intensive Care Units, Neonatal ; Morphine ; Narcotics ; Narcotics - therapeutic use ; Pediatrics ; Preterm neonates ; Retrospective Studies ; Sedatives</subject><ispartof>The Journal of pediatrics, 2017-01, Vol.180, p.92-98.e1</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-7bb001494239cec766a6393a48fe7fd4068ed4f5a076de54a70f81433bd98d4f3</citedby><cites>FETCH-LOGICAL-c414t-7bb001494239cec766a6393a48fe7fd4068ed4f5a076de54a70f81433bd98d4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpeds.2016.08.031$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27614931$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borenstein-Levin, Liron, MD</creatorcontrib><creatorcontrib>Synnes, Anne, MDCM, MHSc</creatorcontrib><creatorcontrib>Grunau, Ruth E., PhD</creatorcontrib><creatorcontrib>Miller, Steven P., MDCM, MAS</creatorcontrib><creatorcontrib>Yoon, Eugene W., MSc</creatorcontrib><creatorcontrib>Shah, Prakesh S., MD, MSc</creatorcontrib><creatorcontrib>Canadian Neonatal Network Investigators</creatorcontrib><title>Narcotics and Sedative Use in Preterm Neonates</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objectives To evaluate patterns of narcotic and sedative use in neonatal intensive care units (NICUs) across Canada using data collected by the Canadian Neonatal Network. Study design We conducted a retrospective observational cohort study of preterm neonates at &lt;33 weeks' gestation and admitted to a participating Canadian Neonatal Network NICU. The proportion of all neonates who received sedative(s), narcotic(s), or either sedative(s), narcotic(s), or both during their NICU stay was calculated for each year. Because opioids are used for premedication before intubation, only continuous infusions of a narcotic drug were included. Variation in narcotics and sedative usage between sites in 2014 was determined using logistic regression analysis, with adjustment for gestational age, surgery, and mechanical ventilation. Results Of 20 744 neonates, 29% of neonates received a narcotic, a sedative, or both; 23% received a narcotic and 17% a sedative. Although no clinically significant changes in drug exposure were documented during the 5-year period, there were statistically significant differences in narcotic and sedative use between sites, ranging from 3% to 41% for narcotic and 2% to 48% for sedative use (aORs 0.2-5.7 and 0.1-15, respectively, P  &lt; .05). Conclusions Exposure to narcotic or sedative agents is highly variable in preterm neonates across Canada despite concerns of adverse outcomes associated with these drugs. The tremendous variation in practice suggests that further research on their current usage, as well as identifying optimal practice procedures is warranted.</description><subject>Canada</subject><subject>Cohort Studies</subject><subject>Drug Utilization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Intensive Care Units, Neonatal</subject><subject>Morphine</subject><subject>Narcotics</subject><subject>Narcotics - therapeutic use</subject><subject>Pediatrics</subject><subject>Preterm neonates</subject><subject>Retrospective Studies</subject><subject>Sedatives</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1LxDAQhoMoun78AkF69NI6abL5OCiI-AWignoO2WQKqd12TbqC_96sqx68eBqGed95mWcIOaRQUaDipK3aBfpU1bmpQFXA6AaZUNCyFIqxTTIBqOuScSl2yG5KLQBoDrBNdmopKNeMTkh1b6MbxuBSYXtfPKG3Y3jH4iVhEfriMeKIcV7c49DbEdM-2Wpsl_Dgu-6Rl6vL54ub8u7h-vbi_K50nPKxlLMZQE7gNdMOnRTCCqaZ5apB2XgOQqHnzdSCFB6n3EpoFOWMzbxWecD2yPF67yIOb0tMo5mH5LDrbI_DMhmqprVUnIHOUraWujikFLExixjmNn4YCmYFyrTmC5RZgTKgTAaVXUffAcvZHP2v54dMFpyuBZjPfA8YTXIBe4c-RHSj8UP4J-Dsj991oQ_Odq_4gakdlrHPBA01qTZgnla_Wr2KCgZCK80-ARuNjVw</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Borenstein-Levin, Liron, MD</creator><creator>Synnes, Anne, MDCM, MHSc</creator><creator>Grunau, Ruth E., PhD</creator><creator>Miller, Steven P., MDCM, MAS</creator><creator>Yoon, Eugene W., MSc</creator><creator>Shah, Prakesh S., MD, MSc</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>Narcotics and Sedative Use in Preterm Neonates</title><author>Borenstein-Levin, Liron, MD ; Synnes, Anne, MDCM, MHSc ; Grunau, Ruth E., PhD ; Miller, Steven P., MDCM, MAS ; Yoon, Eugene W., MSc ; Shah, Prakesh S., MD, MSc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-7bb001494239cec766a6393a48fe7fd4068ed4f5a076de54a70f81433bd98d4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Canada</topic><topic>Cohort Studies</topic><topic>Drug Utilization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Intensive Care Units, Neonatal</topic><topic>Morphine</topic><topic>Narcotics</topic><topic>Narcotics - therapeutic use</topic><topic>Pediatrics</topic><topic>Preterm neonates</topic><topic>Retrospective Studies</topic><topic>Sedatives</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borenstein-Levin, Liron, MD</creatorcontrib><creatorcontrib>Synnes, Anne, MDCM, MHSc</creatorcontrib><creatorcontrib>Grunau, Ruth E., PhD</creatorcontrib><creatorcontrib>Miller, Steven P., MDCM, MAS</creatorcontrib><creatorcontrib>Yoon, Eugene W., MSc</creatorcontrib><creatorcontrib>Shah, Prakesh S., MD, MSc</creatorcontrib><creatorcontrib>Canadian Neonatal Network Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borenstein-Levin, Liron, MD</au><au>Synnes, Anne, MDCM, MHSc</au><au>Grunau, Ruth E., PhD</au><au>Miller, Steven P., MDCM, MAS</au><au>Yoon, Eugene W., MSc</au><au>Shah, Prakesh S., MD, MSc</au><aucorp>Canadian Neonatal Network Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Narcotics and Sedative Use in Preterm Neonates</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>180</volume><spage>92</spage><epage>98.e1</epage><pages>92-98.e1</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objectives To evaluate patterns of narcotic and sedative use in neonatal intensive care units (NICUs) across Canada using data collected by the Canadian Neonatal Network. Study design We conducted a retrospective observational cohort study of preterm neonates at &lt;33 weeks' gestation and admitted to a participating Canadian Neonatal Network NICU. The proportion of all neonates who received sedative(s), narcotic(s), or either sedative(s), narcotic(s), or both during their NICU stay was calculated for each year. Because opioids are used for premedication before intubation, only continuous infusions of a narcotic drug were included. Variation in narcotics and sedative usage between sites in 2014 was determined using logistic regression analysis, with adjustment for gestational age, surgery, and mechanical ventilation. Results Of 20 744 neonates, 29% of neonates received a narcotic, a sedative, or both; 23% received a narcotic and 17% a sedative. Although no clinically significant changes in drug exposure were documented during the 5-year period, there were statistically significant differences in narcotic and sedative use between sites, ranging from 3% to 41% for narcotic and 2% to 48% for sedative use (aORs 0.2-5.7 and 0.1-15, respectively, P  &lt; .05). Conclusions Exposure to narcotic or sedative agents is highly variable in preterm neonates across Canada despite concerns of adverse outcomes associated with these drugs. The tremendous variation in practice suggests that further research on their current usage, as well as identifying optimal practice procedures is warranted.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27614931</pmid><doi>10.1016/j.jpeds.2016.08.031</doi></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2017-01, Vol.180, p.92-98.e1
issn 0022-3476
1097-6833
language eng
recordid cdi_proquest_miscellaneous_1852784309
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Canada
Cohort Studies
Drug Utilization - statistics & numerical data
Humans
Hypnotics and Sedatives - therapeutic use
Infant, Newborn
Infant, Premature
Intensive Care Units, Neonatal
Morphine
Narcotics
Narcotics - therapeutic use
Pediatrics
Preterm neonates
Retrospective Studies
Sedatives
title Narcotics and Sedative Use in Preterm Neonates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T14%3A17%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Narcotics%20and%20Sedative%20Use%20in%20Preterm%20Neonates&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Borenstein-Levin,%20Liron,%20MD&rft.aucorp=Canadian%20Neonatal%20Network%20Investigators&rft.date=2017-01-01&rft.volume=180&rft.spage=92&rft.epage=98.e1&rft.pages=92-98.e1&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/j.jpeds.2016.08.031&rft_dat=%3Cproquest_cross%3E1852784309%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1852784309&rft_id=info:pmid/27614931&rft_els_id=S0022347616306989&rfr_iscdi=true